Skip to main content
Log in

Hepatoprotective Efficacy of a New Phytocomposition of Essential Phospholipids with Glycyrrhizic Acid, Ecdysterone, and Lycopene in Experimental Chronic Hepatitis Compared to Phosphogliv

  • MOLECULAR-BIOLOGICAL PROBLEMS OF DRUG DESIGN AND MECHANISM OF DRUG ACTION
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

A phytocomposition of soy lecithin, glycyrrhizic acid, lycopene, and ecdysterone (conventional name Hepalipin) significantly prevents the development of cytolytic-cholestatic liver damage, contributes to the maintenance of protein- and glycogen-synthesizing functions of the liver, reduces its fatty degeneration, restrains disorders of pigment metabolism, and exhibits an antioxidant effect when administered to experimental animals against the background of developing chronic toxic hepatitis caused by carbon tetrachloride. Hepalipin improves disturbed bile chemical composition and secretion. The continued administration of Hepalipin to rats for another two weeks after the cessation of carbon tetrachloride injections leads to almost complete restoration of all studied parameters to their initial (intact) values. Hepalipin under conditions of experimental chronic hepatitis showed statistically significant advantages compared to Phosphogliv in terms of the intensity of the hepatoprotective effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. O. N. Minushkin, Gastroenterologiya, No. 1 – 2, 2 – 8 (2005).

    Google Scholar 

  2. S. V. Moiseev, Klin. Farmakol. Ter., No. 1 – 2, 10 – 14 (2005).

  3. G. G. Onishchenko, Med. Kur’er, No. 1 – 2, 13 – 15 (2002).

  4. S. D. Podymova, Liver Diseases [in Russian], Meditsina, Moscow (1993).

    Google Scholar 

  5. S. Sherlock and J. Dooley, Diseases of the Liver and Biliary System, 10th Ed., Blackwell Science, Oxford (1997) [Russian translation, GEOTAR-Media, Moscow (1999)].

  6. M. D. Mashkovskii, Drugs [in Russian], RIA Novaya Volna, Moscow (2008), pp. 526 – 529.

    Google Scholar 

  7. I. A. Vasilenko, G. V. Dolgova, G. M. Sorokoumova, et al., Russ. Med. Zh., 18(6), 352 – 355 (2010).

    Google Scholar 

  8. V. F. Uchaikin, V. I. Luchshev, S. N. Zharov, et al., Klin. Med., No. 5, 39 – 42 (2000).

  9. U. Y. Yusupova, N. Sh. Ramazonov, V. N. Syrov, and Sh. Sh. Sagdullaev, Phytoecdysteroids (Properties, Biological Activity and Applications), Springer, Singapore (2002); doi: 10.1007 / 978-981-16-6711-4.

    Article  Google Scholar 

  10. Sh. Sh. Sagdullaev, N. V. Tursunova, S. D. Gusakova, et al., RUz Pat. UZ IAP 05701; Byull., No. 12 (2018).

  11. M. Kates, Techniques of Lipidology: Isolation, Analysis, and Identification of Lipids, Elsevier, New York (1972), 610 pp.

    Google Scholar 

  12. N. Kh. Abdullaev, Pathochemistry and Pathogenetic Therapy of Chronic Hepatitis and Liver Cirrhosis [in Russian], Meditsina, Tashkent (1968).

  13. V. S. Kamyshnikov, Handbook of Clinical and Biochemical Research and Laboratory Diagnostics [in Russian], Medpress-Inform, Moscow (2009).

    Google Scholar 

  14. S. Lo, J. C. Russel, and A. W. Taylor, J. Appl. Physiol., 28(2), 234 – 236 (1970).

    Article  CAS  PubMed  Google Scholar 

  15. B. P. Neri and C. S. Frings, Clin. Chem., 19(10), 1201 – 1202 (1973).

    Article  CAS  PubMed  Google Scholar 

  16. I. D. Stal’naya and T. G. Garishvili, in: Modern Methods in Biochemistry [in Russian], V. I. Orekhovich (ed.), Meditsina, Moscow (1977), pp. 66 – 68.

  17. M. A. Korolyuk, L. I. Ivanova, I. G. Maiorova, and V. E. Tokarev, Lab. Delo, No. 1, 16 – 19 (1988).

  18. E. E. Dubinina, L. A. Sal’nikova, and L. F. Efimova, Lab. Delo, No. 10, 30 – 33 (1983).

  19. Ya. I. Karbach, Biokhimiya, 26(2), 305 – 309 (1961).

    CAS  Google Scholar 

  20. S. M. Drogovoz, Vopr. Med. Khim., No. 4, 397 – 400 (1971).

  21. N. P. Skakun, Probl. Endokrinol., No. 6, 75 – 78 (1956).

  22. V. N. Syrov, Eksp. Klin. Farmakol., No. 5, 61 – 65 (1994).

  23. V. N. Syrov, Farm. Byull. (Karaganda), No. 3 – 4, 111 – 117 (2015).

  24. M. X. Nguyen and S. J. Schwarts, Food Technol. (Chicago), 53, 38 – 45 (1999).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. N. Syrov.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 56, No. 11, pp.3– 8, November, 2022.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Syrov, V.N., Gusakova, S.D., Khushbaktova, Z.A. et al. Hepatoprotective Efficacy of a New Phytocomposition of Essential Phospholipids with Glycyrrhizic Acid, Ecdysterone, and Lycopene in Experimental Chronic Hepatitis Compared to Phosphogliv. Pharm Chem J 56, 1433–1438 (2023). https://doi.org/10.1007/s11094-023-02811-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-023-02811-6

Keywords

Navigation